We view industry not only as a sponsor of our academic activity but rather as partners that can promote new research and innovative developments that will undoubtedly originate from this challenging meeting of interdisciplinary experts of the highest quality. In addition, the IAB, including representatives of the congress sponsors, is expected to guide the organizing committee with innovations and new research that are in demand.
| L. Berman, Pfizer |
Z. Milicevic, Eli Lilly |
| K. Brown Frandsen, Novo Nordisk |
A. Marcus, Medtronic |
| R.L. Chaiken, Pfizer |
G. Panina, Novartis |
| M. Ganz, Roche diagnostics |
C. Rondinone, Roche |
| H. Gringolts, Johnson & Johnson |
P. Stein, Merck |
| B. Hirshberg, AstraZenica |
A.D. Toft, Novo Nordisk |